文章预览
SCI 17 August 2024 Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion A Secondary Analysis of a Randomized Clinical Trial (JAMA Oncology, IF: 22.5) Nasser Altorki, Xiaofei Wang, Bryce Damman, David R. Jones, Dennis Wigle, Jeffrey Port, Massimo Conti, Ahmad S. Ashrafi, Moishe Lieberman, Rodney Landreneau, Kazuhiro Yasufuku, Stephen Yang, John D. Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, David Kozono, Jennifer Mentlick; Everett Vokes, Thomas E. Stinchcombe CORRESPONDENCE TO: nkaltork@med.cornell.edu IMPORTANCE 重要性 The randomized clinical trial Cancer and Leukemia Group B (CALGB) 140503 showed that for patients with clinically staged T1N0 non–small cell lung cancer (NSCLC; 2 cm), sublobar resections were associated with similar oncological outcomes to those after lobar resection. The association of the extent of parenchymal resection with recurrence and survival in patients with tumors pathologically upstaged to T2 based on visceral pleural i
………………………………
